^ 4.04.14.24.3Ovarian Cancer Prevention (PDQ®). NCI. 2013-12-06 [2014-07-01]. (原始内容于2014-07-06).
^ 5.05.15.2Ovarian Cancer Prevention (PDQ®). NCI. 2014-06-20 [2014-07-01]. (原始内容于2014-07-06).
^SEER Stat Fact Sheets: Ovary Cancer. NCI. [18 June 2014]. (原始内容于2014-07-06).
^GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.. Lancet. 8 October 2016, 388 (10053): 1545–1602 [2017-07-28]. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6. (原始内容于2020-10-01).
^GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015.. Lancet. 8 October 2016, 388 (10053): 1459–1544 [2017-07-28]. PMC 5388903. PMID 27733281. doi:10.1016/S0140-6736(16)31012-1. (原始内容于2020-10-01).
^Defining Cancer. National Cancer Institute. [2014-06-10]. (原始内容于2014-06-25).
^Ruddon, Raymond W. Cancer biology 4th ed. Oxford: Oxford University Press. 2007: 223 [2015-09-26]. ISBN 9780195175431. (原始内容于2014-10-06). 引文格式1维护:冗余文本 (link)
^Piek JM, van Diest PJ, Verheijen RH. Ovarian carcinogenesis: an alternative hypothesis. Adv. Exp. Med. Biol. Advances in Experimental Medicine and Biology. 2008, 622: 79–87. ISBN 978-0-387-68966-1. PMID 18546620. doi:10.1007/978-0-387-68969-2_7.
^Moyer, VA; U.S. Preventive Services Task, Force. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.. Annals of internal medicine. 2012-12-18, 157 (12): 900–4. PMID 22964825. doi:10.7326/0003-4819-157-11-201212040-00539.
Cannistra SA. Cancer of the ovary. N. Engl. J. Med. December, 351 (24): 2519–29 [2012-08-06]. PMID 15590954. doi:10.1056/NEJMra041842. (原始内容于2010-01-05).请检查|date=中的日期值 (帮助) 引文格式1维护:日期与年 (link)